Headlines

New Evidence Suggests Pioglitazone Reduces Dementia Risk 42%

blue_brain_3

The results showed a lower dementia incidence with pioglitazone with cumulative long-term use of pioglitazone reducing the dementia risk by 47% (RR=0.53, p=0.029) when compared to non-diabetics.

Differences in sleep duration linked to type 2 diabetes, study reports

sleeping_child

People who have increased sleep duration face a heightened risk of developing type 2 diabetes, according to a University of Bristol study. Researchers examined data waves across more than 20 years, with sleep duration reported at the beginning and end of four cycles – each of which was five years long. The study took place […]

BattleDiabetes – Eating Food in Specific Order Could Benefit Blood Sugar for TII

Food (1)

A study from Weill Cornell Medical College found that people with type 2 diabetes who are also obese could benefit from from eating protein and vegetables before consuming carbohydrates – both in terms of their blood sugar and insulin levels.

ASweetLife – The Danger of Treating Diabetes with Alternative Medicine

yoga-mats-adventure-blog-11

“It was one of the most shocking moments in my life. I drove home crying, feeling desperate and deeply ashamed. How could a health conscious person like me, a yoga teacher, have an incurable disease?” – Rachel Zinman was diagnosed with diabetes in 2008. She’s been practicing yoga for over thirty years and writes the […]

ASweetLife – 11 Diabetes Things I’ll Tell You That Health Care Providers Won’t

11-day_15

So here are 11 things I’ve learned about managing blood sugar from my everyday experience. Any may help you and you’re not likely to hear them from your doctor.

Any added sugar is bad sugar, some experts contend

sugar

Any source of excess sugar contributes to obesity and diabetes, and singling out high-fructose corn syrup might distract consumers from the real health hazards posed by any and all added sugars, many dietitians now say.

Huffpost – What People Who Live to 100 Eat Every Day

Portrait of a 101 year old Costa Rican woman.

There’s one pretty mind-blowing characteristic about the people who live in these five communities throughout the world: Okinawa, Japan; Sardinia, Italy; the Greek island of Ikaria, the Nicoya peninsula of Costa Rica, and Loma Linda, Calif. On average, they live to the ripe age of 100 years old at rates 10 times higher than the […]

The Washington Post – Weary of the needle jab, diabetics yearn for new form of insulin

diabetes-insulin-afrezza

Some people inject themselves three or more times a day, sometimes for 50 or 60 years, tempting them to stop the grueling routine, and interrupting treatment can be dangerous.

Triple Therapy Improves Glycemia in Type 1 Diabetes

trough_level_of_drugs

Dr. Nitesh D. Kuhadiya, MPH, of the State University of New York at Buffalo, and colleagues, conducted a retrospective analysis of 10 patients on continuous glucose monitoring treated with insulin, Victoza (liraglutide) and Farxiga (dapagliflozin).

Insulin Nation – Dual Chamber Artificial Pancreas Prevents Nighttime Lows Better

artificial-pancreas

As we come closer to having an artificial pancreas on the market, there has been a lively debate about what an artificial pancreas should be. The discussion largely centers around whether an artificial pancreas pump should be single-chamber, meaning that it delivers insulin only, or dual-chamber, meaning it would deliver insulin and glucagon.

DiabetesInControl – Blood Biomarkers May Predict Risk of Severe Hypoglycemia

Blood_vessels_1817314c (2)

“Currently, there is no clear way to predict whether a patient with type 2 diabetes will have problems with hypoglycemia if we try to be more aggressive with blood sugar control. Now, there is the possibility that blood biomarkers may predict whether they might have an issue with this or not,” said lead study author, […]

Quell Wearable Device – An Impressive Advancement for Treating Chronic Pain

Product_Band_4

One of the highlights of this year’s ADA Exhibit Hall was NeuroMetrix’s Quell chronic pain management device. Quell is the over the counter version (no prescription needed) of a previous NeuroMetrix device called Sensus – it uses nerve stimulation to treat multiple types of chronic pain, including diabetic neuropathy and fibromyalgia.

IN – A 3-Time Artificial Pancreas Test Subject Speaks

artificial-pancreas

Kelly Close, a noted diabetes advocate and author, used to be last in line to embrace new diabetes technology. In fact, the only reason she even went on insulin pump therapy at all was because her boss requested it. Speaking at the ADA Scientific Sessions in Boston, Close says she was having trouble at her […]

WebMD – Trial Tests Whether TB Shot Fights Type 1 Diabetes

FamousScientistBiography

The proposed five-year study is designed to investigate whether repeated injections of the tuberculosis vaccine bacille Calmette-Guerin (or BCG vaccine) can quiet the immune system attack that causes type 1 diabetes and improve blood sugar levels in people with long-standing diabetes.

Medtronic’s MiniMed Connect – Sending Pump/CGM Data to Smartphones

Screen Shot 2015-06-05 at 11_34_27 AM

At ADA 2015, Medtronic announced FDA Clearance of MiniMed Connect, a keychain device that sends pump/CGM data via Bluetooth to a smartphone app and enables remote monitoring for the caregiver. Launch is slated for this fall for MiniMed 530G and Revel users; it will be $199.

Joslin Diabetes – 3 Ways to Avoid a Serious Diabetes Complication

Kidney transplant

Although people with diabetes are more likely to be diagnosed with kidney disease, you can slow its progress significantly if you catch it early and get treated. Here are three ways you can lower your risk of developing kidney disease.

Fox News – FDA approves mid-stage trial of vaccine to reverse type 1 diabetes

vaccine(1)

Diabetes researchers are hoping that an almost century-old vaccine for preventing tuberculosis may also reverse type 1 diabetes. The FDA has approved a mid-stage trial to test the vaccine, called bacillus Calmette-Guerin (BCG), in 150 adults with advanced cases of the disease.

FDA Approves First-Ever Concentrated Mealtime Insulin

Humalog_Logo

Lilly just announced that the FDA has approved its Humalog 200 units/mL KwikPen (insulin lispro) for type 1 and type 2 diabetes, making it the first concentrated mealtime insulin analog to reach the US market. The pen has already been launched in Europe following its approval there last October. No pricing information for the KwikPen […]

A Simple Solution to a Big Problem, “When Did I Last Take My Insulin?”

timesulin

Timesulin, a pen cap to help patients remember how long it’s been since their last dose of insulin, is now available in the US after raising an impressive $36,189 from a crowdfunding campaign. This is welcome news for patients on injections and comes after Timesulin’s popularity in 40 other countries.

FDA Issues Safety Statement that SGLT-2 Inhibitors May Cause Diabetic Ketoacidosis

Ketoacidosis Image (1)

Diabetic ketoacidosis is a complication of diabetes that occurs when the body produces elevated levels of acidic compounds called ketones, often due to a lack of effective insulin action, which can lead to hospitalization, coma, and even death if left untreated.

Other News

ACLS Class

  • Get ACLS and PALS certified online with ACLSclass.com’s fast programs.
  • Health Partner